The Cell Summit ’25: A Must-Attend Event for Innovators in Cell & Gene Therapy
Join the Premier Cell and Gene Therapy Manufacturing Summit of 2025 WHEN: August 5–6th WHERE: Newfields Art Museum, Indianapolis, IN In the ever-evolving field of cell and gene therapy, the pressure to scale, preserve, and commercialize cell-based products has never been greater. That’s why BioLife Solutions, Azenta Life Sciences, and Entegris have partnered to bring […]
Optimizing Biopreservation Strategies for Apheresis-Derived Cells in Immunotherapeutic Applications
As immunotherapies continue to transform patient care, the biopreservation of apheresis-derived cells plays a vital role in ensuring consistency and quality. This blog explores how advanced preservation strategies—such as optimized cryopreservation and hypothermic storage—help reduce variability, protect cell function, and support the scalable manufacturing of cell-based therapies.
How to prepare early for regulatory submissions from IND to BLA
Early Preparation for IND and BLA Submissions Bringing a new cell and gene therapy (CGT) to market is a complex journey, and one that requires rigorous testing and adherence to safety and regulatory standards. At BioLife Solutions, we have supported many drug manufacturers as they prepare for Investigational New Drug (IND) and Biologics License Application […]
Navigating Current Standards and Compliance for Cell and Gene Therapy (CGT) Storage Containers
Adhering to stringent standards for Cell and Gene Therapy (CGT) storage containers is crucial to ensuring product safety and efficacy. From USP guidelines to regulatory requirements, this blog explores how proper materials, container closure integrity, and visual inspection processes safeguard the integrity of CGT products throughout their lifecycle.
Customer Applications of CryoStor® and HypoThermosol® FRS in Cell & Gene Therapy and Regenerative Medicine
CryoStor and HypoThermosol FRS are essential biopreservation media with over 700 applications in cell and gene therapy and regenerative medicine. Used for preserving T-cells, CAR-T cells, stem cells, and more, these solutions support diverse therapeutic and research needs, ensuring cell viability and functionality for cutting-edge treatments and studies.
What COVID Taught Us About the Benefits of Cryopreservation for Cell-Based Therapies
The COVID-19 pandemic significantly impacted various sectors of healthcare, including the blood and biotherapies field. It disrupted the supply and demand for blood and blood-derived cell products, presenting unprecedented logistical challenges that underscored the benefit of cryopreservation for cell and gene therapies (CGT). According to the National Marrow Donor Program (NMDP), cryopreservation of hematopoietic progenitor […]
BioLife Solutions Expands Evidence Library With Citations of Bioproduction Tools in Scientific and Clinical Research
BioLife Solutions’ refreshed Evidence Library offers a comprehensive collection of published data on the use of biopreservation tools in cell and gene therapy. With enhanced navigation and search capabilities, users can easily explore scientific evidence supporting the adoption of products like CryoStor®, HypoThermosol®, and more.
How the BioLife Solutions Master File Letter Request Process Works for CryoStor® and HypoThermosol® FRS
Cross-Referencing BioLife Master Files CryoStor and HypoThermosol FRS (HTS-FRS) are critical components in many customer cell and gene therapy (CGT) and regenerative medicine processes. Although they are not regulated medical products—meaning they are not classified as drugs, medical devices, or marketed/registered as excipients—they serve a critical role as ancillary/raw materials in cell-based manufacturing processes. BioLife […]